Laboratory properties of cold-adapted influenza B live vaccine strains developed in the US and USSR, and their B/Ann Arbor/1/86 cold-adapted reassortant vaccine candidates
- PMID: 2316285
- DOI: 10.1016/0264-410x(90)90179-p
Laboratory properties of cold-adapted influenza B live vaccine strains developed in the US and USSR, and their B/Ann Arbor/1/86 cold-adapted reassortant vaccine candidates
Abstract
The adaptation of two influenza B strains (B/Leningrad/14/55 and B/Ann Arbor/1/66) to replication at 25 degrees C is described. Comparison of the two viruses indicates that both also exhibit temperature sensitive phenotypes, although that of the virus B/Leningrad/14/55 is less pronounced. When inoculated into ferrets both viruses replicate well in the trachea, but only the B/Leningrad/14/55 cold-adapted virus replicates in the lungs. This virus exhibited a moderate level of attenuation in the animals, in contrast to the B/Ann Arbor/1/66 cold-adapted virus, which was fully attenuated. Reassortant viruses deriving the surface antigens of the contemporary wild type virus B/Ann Arbor/1/86 and most or all of their other genes, from one or other cold-adapted parent, were virtually indistinguishable from their respective cold-adapted parents. The B/Leningrad/14/55 reassortant was slightly more attenuated than its cold-adapted parent in ferrets. These studies extend knowledge of the properties of viruses used to prepare experimental live influenza B human vaccines.
Similar articles
-
Genetic Basis of Attenuation of Cold-Adapted Influenza Strain B/Leningrad/14/17/55 - Backup Master Donor Virus for Influenza Type B Live Attenuated Vaccines.Bull Exp Biol Med. 2020 Mar;168(5):669-672. doi: 10.1007/s10517-020-04777-x. Epub 2020 Apr 4. Bull Exp Biol Med. 2020. PMID: 32248454
-
Evaluation of live attenuated cold-adapted influenza B/Yamagata/16/88 reassortant virus vaccine in healthy adults.J Infect Dis. 1993 Aug;168(2):455-9. doi: 10.1093/infdis/168.2.455. J Infect Dis. 1993. PMID: 8335984 Clinical Trial.
-
The attenuation phenotype conferred by the M gene of the influenza A/Ann Arbor/6/60 cold-adapted virus (H2N2) on the A/Korea/82 (H3N2) reassortant virus results from a gene constellation effect.Virus Res. 1992 Sep 1;25(1-2):37-50. doi: 10.1016/0168-1702(92)90098-t. Virus Res. 1992. PMID: 1413993
-
Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.Drugs R D. 2003;4(5):312-9. doi: 10.2165/00126839-200304050-00007. Drugs R D. 2003. PMID: 12952502 Review.
-
The development of live attenuated cold-adapted influenza virus vaccine for humans.Rev Med Virol. 1999 Oct-Dec;9(4):237-44. doi: 10.1002/(sici)1099-1654(199910/12)9:4<237::aid-rmv252>3.0.co;2-g. Rev Med Virol. 1999. PMID: 10578119 Review.
Cited by
-
Bench-to-bedside review: vaccine protection strategies during pandemic flu outbreaks.Crit Care. 2010;14(2):218. doi: 10.1186/cc8891. Epub 2010 Apr 16. Crit Care. 2010. PMID: 20497595 Free PMC article. Review.
-
Development of an Alternative Modified Live Influenza B Virus Vaccine.J Virol. 2017 May 26;91(12):e00056-17. doi: 10.1128/JVI.00056-17. Print 2017 Jun 15. J Virol. 2017. PMID: 28381580 Free PMC article.
-
Alternative Strategy for a Quadrivalent Live Attenuated Influenza Virus Vaccine.J Virol. 2018 Oct 12;92(21):e01025-18. doi: 10.1128/JVI.01025-18. Print 2018 Nov 1. J Virol. 2018. PMID: 30135124 Free PMC article.
-
Study of Neuraminidase-Inhibiting Antibodies in Clinical Trials of Live Influenza Vaccines.Antibodies (Basel). 2020 May 29;9(2):20. doi: 10.3390/antib9020020. Antibodies (Basel). 2020. PMID: 32485797 Free PMC article.
-
Assessment of trivalent live influenza vaccines in MDCK cell line.MethodsX. 2021 Jul 4;8:101442. doi: 10.1016/j.mex.2021.101442. eCollection 2021. MethodsX. 2021. PMID: 34430331 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical